PROCESSES FOR THE PREPARATION OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF

87958287 ABSTRACT Provided are processes for the preparation of enantiomerically enriched or enantiomerically pure 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine- 2,6-dione, or a pharmaceutically acceptable form thereof. Date Recue/Date Received 2021-02-11 87958287 ABRÉGÉ : I...

Full description

Saved in:
Bibliographic Details
Main Authors FEIGELSON, GREGG B, TRAVERSE, JOHN F, LEONG, WILLIAM W, ZHANG, CHENGMIN, COHEN, BENJAMIN M
Format Patent
LanguageEnglish
French
Published 04.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:87958287 ABSTRACT Provided are processes for the preparation of enantiomerically enriched or enantiomerically pure 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine- 2,6-dione, or a pharmaceutically acceptable form thereof. Date Recue/Date Received 2021-02-11 87958287 ABRÉGÉ : Il est décrit des procédés de préparation de 3-(4-((4-(morpholinométhyl)benzyl)oxy)-1-oxoisoindolin-2-yl)pipéridine-2,6-dione énantiomériquement enrichi ou énantiomériquement pur, ou de sa forme pharmaceutiquement acceptable. Date reçue / Date Received 2021-02-11
Bibliography:Application Number: CA20133108974